Home › Metastatische kanker › District of Columbia › Washington
Metastatische kanker klinische studies in Washington, DC
43 studies voor Metastatische kanker zoeken deelnemers op locaties in en rond Washington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekruterenFase 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekruterenFase 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruterenFase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruterenFase 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruterenFase 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mijl verwijderd
- Maryland Oncology Hematology, P.A., Bethesda · 7 mijl verwijderd
- Maryland Oncology Hematology, P.A., Largo · 11 mijl verwijderd
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RekruterenFase 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 mijl verwijderd
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
RekruterenFase 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
RekruterenFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mijl verwijderd
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
RekruterenFase 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mijl verwijderd
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruterenFase 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mijl verwijderd
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
RekruterenFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mijl verwijderd
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RekruterenFase 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
RekruterenFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mijl verwijderd
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
RekruterenFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mijl verwijderd
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
RekruterenFase 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mijl verwijderd
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruterenFase 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mijl verwijderd
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekruterenFase 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekruterenFase 3
- American Oncology Partners, P.A., Bethesda · 7 mijl verwijderd
Studying TAK-243 in Patients With Advanced Cancer
RekruterenFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mijl verwijderd
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
RekruterenFase 2/3
- The Center for Cancer and Blood Disorders, Bethesda · 7 mijl verwijderd
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekruterenFase 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekruterenFase 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruterenFase 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RekruterenFase 1
- National Cancer Institute, Bethesda · 7 mijl verwijderd
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
RekruterenFase 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RekruterenFase 1
- American Oncology Partners of Maryland, Bethesda · 7 mijl verwijderd
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruterenFase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mijl verwijderd
- Massive Bio SYNERGY-AI site, Bethesda · 7 mijl verwijderd
Metastatische kanker studies in andere steden
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Dallas, TX42 studies
- Seattle, WA39 studies
Andere studies in Washington
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker55 studies
- Borstkanker46 studies
- Longkanker41 studies
- Prostaatkanker38 studies
- Obesitas33 studies
- Colorectale kanker29 studies
- Cardiovasculaire ziekte28 studies
- Blasenkanker26 studies
- Acute myeloïde leukemie24 studies
- Eierstokkanker23 studies
- Lymfoom23 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.